TOKIO rationale and protocol: a phase II study to evaluate the activity and safety of third-line tyrosine kinase inhibitor after 2 tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Andrea Necchi Elena Verzoni Giuseppe Procopio Paolo Grassi |
| Publication date | June 20, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |